Cover Image
Market Research Report

US Next-generation Sequencing Market

Published by Frost & Sullivan Product code 306533
Published Content info 111 Pages
Delivery time: 1-2 business days
Price
Back to Top
US Next-generation Sequencing Market
Published: June 20, 2014 Content info: 111 Pages
Description

Marketplace Evolves in Preparation for Clinical Sequencing Windfall

The total market, as defined by this study, includes next-generation sequencing instruments and reagents in the United States. Instruments include those that use newer technology than traditional capillary electrophoresis (CE) sequencing, such as sequencing-by-synthesis, sequencing-by-ligation, single-molecule sequencing, and semiconductor sequencing. This research service offers a discussion of the key market drivers and restraints, revenue forecasts, and product types, as well as important trends affecting growth. This analysis also presents key companies to watch, major market dynamics, and strategic recommendations for competitors.

Key Questions This Study Will Answer

  • When will the long-anticipated clinical sequencing market emerge into prominence?
  • What effects will the declining cost to sequence a genome and reduced instrument prices have on market advancement?
  • Which anticipated new market entrants and novel technologies should be on competitors' radar, and why?
  • How will the competitive structure change over time? Is it ripe for acquisitions?
  • What customer bases offer the best opportunities for growth?
  • What regulatory, reimbursement, and implementation issues stand in the way of clinical adoption of next-generation sequencing?
Table of Contents
Product Code: ND5A-01-00-00-00

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

  • 1. Key Findings
  • 2. Key Findings (continued)
  • 3. Key Findings (continued)
  • 4. Scope and Segmentation
  • 5. Key Questions This Study Will Answer
  • 6. Measurements
  • 7. CEO's Perspective
  • 8. Key Companies to Watch
  • 9. Key Companies to Watch (continued)
  • 10. Executive Summary-3 Big Predictions

2. MARKET OVERVIEW

Market Overview

  • 1. Market Background
  • 2. Market Segmentation
  • 3. Global Market Perspective
  • 4. Defining Healthcare Trends in the Future

3. COMPETITIVE PLAYBOOK

Competitive Playbook

  • 1. New Market Opportunities
  • 2. New Market Opportunities (continued)
  • 3. New Market Opportunities (continued)
  • 4. New Market Opportunities (continued)
  • 5. New Market Opportunities (continued)
  • 6. Merger, Acquisition, and Partnership Assessment
  • 7. Merger, Acquisition, and Partnership Assessment (continued)
  • 8. Merger, Acquisition, and Partnership Assessment (continued)

4. DRIVERS, RESTRAINTS, AND TRENDS-TOTAL NEXT-GENERATION SEQUENCING MARKET

Drivers, Restraints, and Trends-Total Next-generation Sequencing Market

  • 1. Market Drivers
  • 2. Market Restraints
  • 3. Market Impact of Top 10 Trends

5. FORECASTS AND TRENDS-TOTAL NEXT-GENERATION SEQUENCING MARKET

Forecasts and Trends-Total Next-generation Sequencing Market

  • 1. Measurements
  • 2. Forecast Assumptions and Methodology
  • 3. Total Next-generation Sequencing Market-Revenue Forecast
  • 4. Total Next-generation Sequencing Market-Revenue Forecast by Product Type
  • 5. Revenue Forecast by Product Type
  • 6. Total Next-generation Sequencing Market-Percent Revenue Forecast by Product Type
  • 7. Revenue Forecast Discussion
  • 8. Revenue Forecast Discussion (continued)
  • 9. Procurement Process

6. COMPETITIVE ENVIRONMENT

Competitive Environment

  • 1. Competitive Environment-Instruments
  • 2. Instruments Product Analysis-Illumina
  • 3. Instruments Product Analysis-Illumina (continued)
  • 4. Instruments Product Analysis-Illumina (continued)
  • 5. Instruments Product Analysis-Illumina (continued)
  • 6. Instruments Product Analysis-Life Technologies
  • 7. Instruments Product Analysis-Life Technologies (continued)
  • 8. Instruments Product Analysis-Life Technologies (continued)
  • 9. Instruments Product Analysis-Roche
  • 10. Instruments Product Analysis-Roche (continued)
  • 11. Instruments Product Analysis-Roche (continued)
  • 12. Instruments Product Analysis-Pacific Biosciences
  • 13. Instruments Product Analysis-Pacific Biosciences (continued)
  • 14. Instruments Product Analysis-Pacific Biosciences (continued)
  • 15. NGS Platform Trending-Instruments
  • 16. Future Competitors-Instruments
  • 17. NHGRI-funded Sequencing Technology Development
  • 18. NHGRI-funded Sequencing Technology Development (continued)
  • 19. NHGRI-funded Sequencing Technology Development (continued)
  • 20. NHGRI-funded Sequencing Technology Development (continued)
  • 21. SWOT Analysis-Instruments
  • 22. SWOT Analysis-Instruments (continued)
  • 23. SWOT Analysis-Instruments (continued)
  • 24. Competitive Environment-Reagents
  • 25. Reagents Product Analysis
  • 26. Reagents Product Analysis (continued)
  • 27. Reagents Product Analysis (continued)
  • 28. Reagents Product Analysis (continued)
  • 29. Reagents Product Trends

7. NEXT-GENERATION SEQUENCING INSTRUMENTS MARKET BREAKDOWN

Next-generation Sequencing Instruments Market Breakdown

  • 1. Next-generation Sequencing Instruments Market-Market Engineering Measurements
  • 2. Next-generation Sequencing Instruments Market-Revenue Forecast
  • 3. Revenue Forecast Discussion
  • 4. Next-generation Sequencing Instruments Market-Market Share Analysis
  • 5. Next-generation Sequencing Instruments Market-Market Share Analysis (continued)

8. NEXT-GENERATION SEQUENCING REAGENTS MARKET BREAKDOWN

Next-generation Sequencing Reagents Market Breakdown

  • 1. Next-generation Sequencing Reagents Market-Market Engineering Measurements
  • 2. Next-generation Sequencing Reagents Market-Revenue Forecast
  • 3. Revenue Forecast Discussion
  • 4. Next-generation Sequencing Reagents Market-Percent Revenue Forecast by Usage
  • 5. Next-generation Sequencing Reagents Market-Market Share Analysis

9. THE LAST WORD

The Last Word

  • 1. The Last Word-3 Big Predictions
  • 2. The Last Word-Competitor Base
  • 3. The Last Word-Creation of Databases to Increase the Clinical Utility of the Genome
  • 4. The Last Word-Creation of Databases to Increase the Clinical Utility of the Genome (continued)
  • 5. The Last Word-Payor and Physician Buy-in
  • 6. The Last Word-Payor and Physician Buy-in (continued)
  • 7. The Last Word-Payor and Physician Buy-in (continued)
  • 8. Legal Disclaimer

10. APPENDIX

Appendix

  • 1. Drivers Explained
  • 2. Drivers Explained (continued)
  • 3. Drivers Explained (continued)
  • 4. Drivers Explained (continued)
  • 5. Drivers Explained (continued)
  • 6. Drivers Explained (continued)
  • 7. Restraints Explained
  • 8. Restraints Explained (continued)
  • 9. Restraints Explained (continued)
  • 10. Restraints Explained (continued)
  • 11. Restraints Explained (continued)
  • 12. Additional Sources of Information
  • 13. Methodology
  • 14. Learn More-Next Steps
Back to Top